BetterLife Pharma Inc

Research BetterLife Pharma Inc (NPAU) on Bullrun: market cap EUR 7.85M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNPAU
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 7.85M
• Financial periodQ3 2025
• Net income-EUR 494.48K
• Free cash flow-EUR 172.31K

Valuation Snapshot

latest market cap is EUR 7.85M.

About BetterLife Pharma Inc

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections.

Frequently asked questions

What is BetterLife Pharma Inc's market cap?

BetterLife Pharma Inc's market capitalization is EUR 7.85M.

What does BetterLife Pharma Inc do?

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.